CD8 T Cell Sensing of Type I Interferon Impacts Anergy
European Journal of Immunology · 2026-05 · 56 (5)
DOI: 10.1002/eji.70192 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 07.05.2026. Verfasst von Anne S Haefke und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology, ETH Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Interferon Type I, CD8-Positive T-Lymphocytes, Clonal Anergy. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ETH Zurich (Eidgenössische Technische Hochschule Zürich), Swiss National Science Foundation (Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung), Max-Planck-Gesellschaft.
Abstract (Originalsprache)
Peripheral tolerance is indispensable for the maintenance of immune homeostasis, allowing protective immunity while limiting responses to self‐antigens. CD8 T cells activated in the absence of co‐stimulation and pro‐inflammatory cytokines are either deleted, rendered anergic, or actively suppressed. These mechanisms are well established, but the cues determining the mode and depth of peripheral tolerance remain incompletely understood. Here, we identify type I interferon (IFN‐I) signalling in T cells as a key modulator of peripheral tolerance in the absence of infection. In the complete absence of IFN‐I signalling, autoreactive CD8 T cells are rendered anergic, and their expansion, phenotype and function are tightly controlled. Basal levels of IFN‐I are sufficient for self‐reactive CD8 T cells to expand and retain partial effector functions in the absence of viral infections. This is dependent on T cell‐intrinsic IFN‐I sensing and is associated with the generation of a partially anergic, TCF1 + CD8 T cell subset that can contribute to a pathogen‐specific immune response. Collectively, our results suggest that elevated basal IFN‐I levels limit anergy induction, providing a potential mechanistic explanation for the association of baseline inflammation with the development of autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
- Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Förderung
- ETH Zurich (Eidgenössische Technische Hochschule Zürich)
- Swiss National Science Foundation (Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung)
- Max-Planck-Gesellschaft
- Promedica Stiftung
Zitieren
APA
Haefke, A. S., Gröber, H., Sandu, I., Skipness, V., Pantouloufos, N., Gräbnitz, F., Tuchel, M. E., Zangger, N., Stark, D., Kříž, M., Cristinzio, C., Pircher, H., Spörri, R., Quast, I., & Oxenius, A. (2026). CD8 T Cell Sensing of Type I Interferon Impacts Anergy. European Journal of Immunology, 56(5). https://doi.org/10.1002/eji.70192
Vancouver
Haefke AS, Gröber H, Sandu I, Skipness V, Pantouloufos N, Gräbnitz F, et al. CD8 T Cell Sensing of Type I Interferon Impacts Anergy. European Journal of Immunology. 2026;56(5). doi:10.1002/eji.70192
BibTeX
@article{Haefke2026,
author = {Haefke, Anne S and Gröber, Hanna and Sandu, Ioana and Skipness, Vanessa and Pantouloufos, Nikos and Gräbnitz, Fabienne and Tuchel, Marie-Elen and Zangger, Nathan and Stark, Dominique and Kříž, Marvin and Cristinzio, Carmine and Pircher, Hanspeter and Spörri, Roman and Quast, Isaak and Oxenius, Annette},
title = {CD8 T Cell Sensing of Type I Interferon Impacts Anergy},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {5},
doi = {10.1002/eji.70192}
}
EUVIMED